Search Results - "POCKAJ, B"

Predictive factors of upstaging DCIS to invasive carcinoma in BCT vs mastectomy by Sheaffer, W.W., Gray, R.J., Wasif, N., Stucky, C.C., Cronin, P.A., Kosiorek, H.E., Basu, A., Pizzitola, V.J., Patel, B., Giurescu, M.E., Lorans, R., McCullough, A.E., Ocal, I.T., Pockaj, B.A.

“…Upstaging from DCIS to invasive ductal carcinoma varies widely from 0 to 59%. We aim to identify risk factors associated with upstaging in all DCIS patients…”
Get full text

The changing landscape of axillary surgery: Which breast cancer patients may still benefit from complete axillary lymph node dissection? by McGhan, L.J., Dueck, A.C., Gray, R.J., Wasif, N., McCullough, A.E., Pockaj, B.A.

“…Background and Objectives Many breast cancer patients undergoing completion axillary lymph node dissection (CALND) for sentinel lymph node (SLN) metastases…”
Get full text

The clinical behavior of desmoplastic melanoma by Jaroszewski, Dawn E, Pockaj, Barbara A, DiCaudo, David J, Bite, Uldis

“…Background: Desmoplastic melanoma (DM) is a rare variant of malignant melanoma. A better understanding of the clinical course of DM will impact on its…”
Get full text

Sentinel lymph node metastases detected by immunohistochemistry only do not mandate complete axillary lymph node dissection in breast cancer by Gray, R. J., Pockaj, B. A., Conley, C. R.

Get full text

Breast cancer: Presentation and intervention in women with gastrointestinal metastasis and carcinomatosis by McLemore, E. C., Pockaj, B. A., Reynolds, C. A., Gray, R. J., Grant, C. S., Donohue, J. H.

Get full text

MO-0137 MC1635: final results of a randomized phase III trial of hypofractionated radiotherapy for breast CA by Vargas, C., Corbin, K., DeWees, T., McGee, L., Mutter, R., Vallow, L., Shumway, D., Vern-Gross, T., Halyard, M., Keole, S., Park, S., William, W., sarah, M., Golafshar, M., Laughlin, B., Thorpe, C., Pockaj, B.

Get full text

Intra-operative electron irradiation and external beam irradiation after lumpectomy in patients with T1/T2N0M0 breast cancer: Preliminary results by Pockaj, B. A., Wong, W. W., Gray, R. J., Halyard, M. Y., Vora, S. A., Schild, S. E., Apsey, H. A.

Get full text

Abstract P1-11-13: Depomedroxyprogesterone therapy for hot flashes in survivors of ER-expressing breast cancer: Impact on recurrence and survival by Ertz-Archambault, N, Rogoff, L, Kosiorek, H, Ernst, B, Anderson, K, Pockaj, B, Gray, R, Northfelt, D

“…Abstract Background Survivors of ER-expressing operable breast cancer (ER+BC) generally do not receive hormone replacement therapy for menopausal symptoms due…”
Get full text

Abstract PD2-11: Contrast-enhanced spectral mammography is comparable to MRI in the assessment of residual breast cancer following neoadjuvant systemic therapy by Hilal, T, Covington, M, Sugi, M, Zhang, N, Pockaj, B, Northfelt, D, Ocal, IT, Patel, BK

“…Abstract OBJECTIVE: Currently, no study has assessed the performance of contrast-enhanced spectral mammography (CESM) in evaluating tumor response in breast…”
Get full text

Abstract P4-02-03: Pre-neoadjuavnt therapy MRI phenotype can predict response to neoadjuvant endocrine therapy by Hilal, T, Covington, M, Pockaj, B, Northfelt, D, Wu, T, Zwart, C, Li, J, Patel, BK

“…Abstract OBJECTIVE: Neoadjuvant endocrine therapy (NET) is increasingly used for the treatment of low and intermediate grade, hormone receptor positive, HER2…”
Get full text

MC1732: Pilot/Phase II Trial of Hypofractionated Radiotherapy to the Whole Breast Alone Before Breast Conserving Surgery by Thorpe, C.S., DeWees, T.A., Vallow, L.A., Pockaj, B.A., Cronin, P.A., Halyard, M.Y., Vern-Gross, T.Z., McGee, L.A., Mclaughlin, S., Golafshar, M.A., Bulman, G.F., Vargas, C.E.

“…To report the results of our phase II trial of breast cancer patients treated with hypofractionated whole breast radiation therapy (RT) prior to breast…”
Get full text

Ventral hernia synthetic mesh repair infected by Mycobacterium fortuitum by Matthews, M R, Caruso, D M, Tsujimura, R B, Smilack, J D, Pockaj, B A, Malone, J M

“…We report the occurrence of a refractory infection caused by the "rapidly growing" nontuberculous mycobacterium, Mycobacterium fortuitum, after incisional…”
Get more information

Infectious complications associated with interleukin-2 administration: a retrospective review of 935 treatment courses by Pockaj, B A, Topalian, S L, Steinberg, S M, White, D E, Rosenberg, S A

“…To determine if interleukin-2 (IL-2)-treated patients are prone to develop clinically significant infections, a retrospective review of 519 patients who…”
Get more information

MC1635: Randomized Phase III Trial of Hypofractionated Radiotherapy to the Whole Breast After Breast Conserving Surgery by Thorpe, C.S., DeWees, T.A., Corbin, K.S., McGee, L.A., Mutter, R.W., Vallow, L.A., Shumway, D., Vern-Gross, T.Z., Halyard, M.Y., Keole, S.R., Park, S.S., Wong, W.W., Pockaj, B.A., Mclaughlin, S., Golafshar, M.A., Bulman, G.F., Vargas, C.E.

“…Hypofractionated radiation therapy (RT) for localized breast cancer improves patient convenience and reduces treatment cost. Here, we report the early results…”
Get full text

Abstract P5-04-19: JAK2 copy number and targeted JAK2 inhibition of TNBC cell lines by Chen, M, Andreozzi, M, Gonzalez-Malerva, L, Eaton, S, Pockaj, B, Barrett, MT, Anderson, KS

“…Abstract Background A subset of triple negative breast cancers (TNBC) has somatic amplification of chromosome 9p24.1, encoding PD-L1, PD-L2, and JAK2 (the…”
Get full text

Abstract P6-07-17: A novel fluorescence in situ hybridization assay to detect 9p24.1 amplification in triple negative breast cancer by Chen, M, Andreozzi, M, Pockaj, B, Barrett, MT, Ocal, IT, McCullough, AE, Anderson, KS

“…Abstract Introduction: Previously, we detected amplification of chromosome 9p24.1 encoding PDL1, PDL2, and JAK2 (the PDJ amplicon) in up to 25% of triple…”
Get full text

Abstract P2-04-18: JAK2 and PD-L1 amplification enhance the dynamic expression of PD-L1 in triple negative breast cancer by Chen, M, Pockaj, B, Andreozzi, M, Barrett, MT, Ocal, IT, McCullough, AE, Krishna, S, Anderson, KS

“…Abstract Background: Triple negative breast cancer (TNBC) is a heterogeneous disease. Amplification of chromosome 9p24.1 encoding JAK2 and PD-L1 has been…”
Get full text

Abstract P4-01-21: Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer by McDonald, BR, Contente-Cuomo, T, Sammut, S-J, Ernst, B, Odenheimer-Bergman, A, Perdigones, N, Chin, S-F, Farooq, M, Cronin, PA, Anderson, KS, Kosiorek, H, Northfelt, D, McCullough, A, Patel, B, Caldas, C, Pockaj, B, Murtaza, M

“…Abstract Background: Circulating tumor DNA (ctDNA) analysis holds potential for minimal residual disease (MRD) detection in early stage breast cancer. However,…”
Get full text

Histopathological analysis of metastatic melanoma deposits in patients receiving adoptive immunotherapy with tumor-infiltrating lymphocytes by COLE, D. J, TAUBENBERGER, J. K, POCKAJ, B. A, YANNELLI, J. R, CARTER, C, CARRASQUILLO, J, LEITMAN, S, STEINBERG, S. M, ROSENBERG, S. A, YANG, Y. C

“…Tumor-infiltrating lymphocytes (TIL) from a wide range of human and murine tumors can be expanded in vitro using interleukin-2 (IL-2). These TIL are cytolytic…”
Get full text

Rectal Bleeding from a Mucous Fistula Secondary to a Dieulafoy's Lesion by Abdelmalek, Manal F, Pockaj, Barbara A, Leighton, Jonathan A

“…Dieulafoy's lesion is a submucosal artery associated with a minute mucosal defect, and it is an extremely rare cause of profuse but intermittent…”
Get full text